U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
136051136051Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHDCompletedNo Results AvailableADHDDrug: Sedariston|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00782080
136052136052Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell LeukemiaActive, not recruitingNo Results AvailableLeukemiaDrug: Midostaurinhttps://ClinicalTrials.gov/show/NCT00782067
136053136053Evaluation of Post Burn Rehabilitation Population for Itch ControlCompletedNo Results AvailablePruritus|Itching|Burn PruritusOther: Provase|Other: Control moisturizerhttps://ClinicalTrials.gov/show/NCT00782054
136054136054Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerTerminatedNo Results AvailableUterine NeoplasmsDrug: Oxaliplatin|Drug: 5-FluoroUracil|Drug: Folinic acidhttps://ClinicalTrials.gov/show/NCT00782041
136055136055Integrating Well-Woman and Well-Baby Care to Improve Parenting and Family WellnessNot yet recruitingNo Results AvailablePrimary CareOther: Centering parenting/Group well child care|Other: Standard Carehttps://ClinicalTrials.gov/show/NCT00782028
136056136056Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery DiseaseActive, not recruitingNo Results AvailableVascular Disease|Endothelial Dysfunction|Heart Disease|Cardiovascular Diseases|HypertensionDietary Supplement: Almondshttps://ClinicalTrials.gov/show/NCT00782015
136057136057Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard TherapyCompletedNo Results AvailableAdvanced Solid TumorsBiological: IMC-18F1https://ClinicalTrials.gov/show/NCT00782002
136058136058Ultrasonography as a Biomarker in Early Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT00781989
136059136059Antiviral Activity of AZD7295 in HCV CarriersCompletedNo Results AvailableHepatitis CDrug: AZD7295|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00781976
136060136060Implementing Sleep Interventions for Older VeteransCompletedHas ResultsInsomniaBehavioral: CBTI|Behavioral: CBTI|Behavioral: Sleep educationhttps://ClinicalTrials.gov/show/NCT00781963
136061136061Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial DiseaseActive, not recruitingHas ResultsPeripheral Arterial DiseaseDietary Supplement: Flaxseedhttps://ClinicalTrials.gov/show/NCT00781950
136062136062Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceCompletedHas ResultsMetabolism and Nutrition Disorder|ObesityDrug: liraglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00781937
136063136063Interventional Sonography Guided by Image FusionCompletedNo Results AvailableFocal Liver Lesions|Focal Lesions in the AbdomenProcedure: biopsyhttps://ClinicalTrials.gov/show/NCT00781924
136064136064A Study of IMC-A12 in Islet Cell CancerActive, not recruitingNo Results AvailableCarcinoma|Neuroendocrine TumorsBiological: IMC-A12 (cixutumumab)|Drug: depot octreotidehttps://ClinicalTrials.gov/show/NCT00781911
136065136065Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt SiteActive, not recruitingNo Results AvailableOpiate AddictionDrug: Depot naltrexone|Other: Treatment as Usual (TAU)https://ClinicalTrials.gov/show/NCT00781898
136066136066A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH PatientsCompletedNo Results AvailablePulmonary Arterial HypertensionDrug: Beraprost sodium modified releasehttps://ClinicalTrials.gov/show/NCT00781885
136067136067Mesenchymal Stem Cells for the Treatment of MSActive, not recruitingNo Results AvailableMultiple SclerosisBiological: injection of autologous stem cellshttps://ClinicalTrials.gov/show/NCT00781872
136068136068Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.CompletedHas ResultsVitreomacular AdhesionDrug: 125 µg Ocriplasmin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00781859
136069136069Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED)CompletedNo Results AvailableSolid TumorDrug: ridaforolimus|Drug: bevacizumabhttps://ClinicalTrials.gov/show/NCT00781846
136070136070Use of Implanted Microstimulators for Decreasing Spasticity and Improving Motion Following Spinal Cord InjuryTerminatedNo Results AvailableSpinal Cord Injury at C5-C7 Level With Incomplete LesionDevice: Radio Frequency Microstimulatorhttps://ClinicalTrials.gov/show/NCT00781833
136071136071Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea PasteCompletedNo Results AvailableOnychomycosisDrug: Bifonazole cream 1%|Drug: Placebo creamhttps://ClinicalTrials.gov/show/NCT00781820
136072136072Rehabilitation and Outcome for Patients on LVAD SupportRecruitingNo Results AvailableExercise Capacity|Quality of LifeOther: multi-module rehabilitation programhttps://ClinicalTrials.gov/show/NCT00781807
136073136073Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic PatientsTerminatedNo Results AvailableSchizophreniaDrug: NSA-789 at 2 different doseshttps://ClinicalTrials.gov/show/NCT00781794
136074136074Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity ConditioningTerminatedNo Results AvailableGraft Versus Host DiseaseDrug: Alemtuzumabhttps://ClinicalTrials.gov/show/NCT00781781
136075136075Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent NauseaCompletedNo Results AvailableNausea|VomitingDrug: Standard PO ondansetron + dexamethasone|Drug: aprepitant (MK-869) + PO ondansetron + dexamethasonehttps://ClinicalTrials.gov/show/NCT00781768
136076136076Treating Schizophrenic Smokers: Effects on Craving, Cues and WithdrawalWithdrawnNo Results AvailableTobacco Use DisorderDrug: varenicline|Behavioral: Adaptation of Motivational Interviewinghttps://ClinicalTrials.gov/show/NCT00781755
136077136077AZD6765 Severe Major Depressive Disorder (MDD) IVCompletedNo Results AvailableMajor Depressive DisorderDrug: AZD6765|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00781742
136078136078Yoga for Kyphosis TrialCompletedNo Results AvailableKyphosisBehavioral: Yoga, one hour class, 3 times per week, for 24 weeks|Behavioral: Luncheon Seminar Series, once per month, for 24 weekshttps://ClinicalTrials.gov/show/NCT00781729
136079136079Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in ChinaNot yet recruitingNo Results AvailableMyocardial Infarction|Coronary Artery DiseaseDevice: Drug eluting coronary stent systemhttps://ClinicalTrials.gov/show/NCT00781716
136080136080Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN)CompletedNo Results AvailableMajor DepressionOther: DIAMOND depression care modelhttps://ClinicalTrials.gov/show/NCT00781703

* Görseller ve İçerik tekif hakkına sahip olabilir